$50.880
+0.926 (+1.82%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
TVTX Prediction & Forecast by Similar Chart Analysis
Alphio's TVTX stock price prediction model matches the current Travere Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $49.01 (-3.60%). The 1-week path is $49.70 (-2.25%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Travere Therapeutics Inc Stock?
Travere Therapeutics Inc is currently a hold. The stock is priced at $50.08, which is significantly below the analyst price targets ranging from $75 to $89, indicating potential upside. However, the RSI is at 31.377, suggesting the stock is oversold, and the forward P/E ratio is 39.84, indicating high valuation expectations. The main risk is the recent net loss of $34.79 million in Q2 2026, which is higher than the previous year's loss, highlighting ongoing financial challenges.
TVTX stock price ended at $50.88 on Tuesday, after rising +1.82%
Travere Therapeutics Inc (TVTX) last closed at $50.8450012, losing -0.07%. These facts feed the 1-day and 1-week TVTX price prediction above.
Forecast Drivers
Travere Therapeutics Inc (TVTX) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bullish
Similar Chart Patterns
Stocks whose recent price path most closely matches TVTX, ranked by similarity.
Seasonality analysis for TVTX
Historically the probability of a positive October return for TVTX is 100.00%. October offers the highest probability of a positive month at 100.00%, while January is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for TVTX
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Oct 2026 | $26.19 | $28.89 | $34.13 | -43.18% |
| Nov 2026 | $18.78 | $21.70 | $29.21 | -57.32% |
| Dec 2026 | $17.95 | $22.30 | $24.24 | -56.13% |
In 2026, Travere Therapeutics Inc (TVTX) is projected to range from $17.95 to $34.13.
Travere Therapeutics Inc 2026 monthly forecast
In Oct 2026, Travere Therapeutics Inc is projected to average $28.89, with a low of $26.19 and high of $34.13.
In Nov 2026, Travere Therapeutics Inc is projected to average $21.70, with a low of $18.78 and high of $29.21.
In Dec 2026, Travere Therapeutics Inc is projected to average $22.30, with a low of $17.95 and high of $24.24.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.